PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Program of Advanced Professional Master of Public Health, Global Health, Yale School of Public Health , New Haven, CT, USA.\', \'Section of Rheumatology, Allergy & Immunology, Yale University School of Medicine , New Haven, CT, USA.\', \'Department of Allergy and Immunology, VA Medical Center , West Haven, CT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/13543784.2020.1840549
?:doi
?:hasPublicationType
?:journal
  • Expert opinion on investigational drugs
is ?:pmid of
?:pmid
?:pmid
  • 33094669
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.166
?:rankingScore_hIndex
  • 92
?:title
  • Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33094669>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33094669>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all